The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kamchatnov P.R.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Improvement of the efficacy and safety of the treatment of patients with low back pain

Authors:

Kamchatnov P.R.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(10): 28‑33

DOI: 10.17116/jnevro201611610128-33

Read: 4282 times

Download PDF (RU)
Contact the author
Table of contents

IMPROVEMENT OF THE EFFICACY AND SAFETY OF THE TREATMENT OF PATIENTS WITH LOW BACK PAIN
IMPROVEMENT OF THE EFFICACY AND SAFETY OF THE TREATMENT OF PATIENTS WITH LOW BACK PAIN

To cite this article:

Kamchatnov PR. Improvement of the efficacy and safety of the treatment of patients with low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(10):28‑33. (In Russ.)
https://doi.org/10.17116/jnevro201611610128-33

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Pharmacological pain mana­gement in pediatric inte­nsive care. Russian Journal of Pain. 2025;(1):56-61
Characteristics, treatment features and in-hospital mortality of patients with myocardial infa­rction over 75 years old in Russia acco­rding to the REGION-IM regi­stry. Russian Cardiology Bulletin. 2025;(1):22-38
Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coro­nary inte­rvention. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):191-200
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Postoperative peri­tonitis: epidemiology, diagnosis, surgical treatment and prognosis. Piro­gov Russian Journal of Surgery. 2025;(6):104-111
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44
Abstract:

Low back pain (LBP) is an extremely widespread syndrome in the population. Nonsteroidal Inflammatory drugs are most frequently used in treatment of patients with LBP. The use of these drugs causes adverse effects, the risk of which can be minimized. To decrease the risk, B-group vitamins are used in the complex treatment. The possibility of simultaneous using of artrozan (meloxicam) and cyanocobalamine (B-group vitamin complex) in the treatment of LBP is considered.

Keywords:

low back pain
nonsteroid antiinlammatory drugs
meloxicam
thiamine
pyridoxine
cyanocobalamine
treatment

Authors:

Kamchatnov P.R.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Close metadata

References:

  1. Hoy D, March L, Brooks P, Blyth F, Woolf A. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Аnn Rheum Dis. 2014;73:968-974. doi: 10.1136/annrheumdis-2013-204428
  2. Hoy D, Brooks P, Blyth F. The epidemiology of low back pain. Best Pract Res Clin Rheumatol. 2010;24:769-781. doi: 10.1016/j.berh.2010.10.002
  3. Esin RG, Esin OR, Ahmadeeva GD, Salihova GV. Bol v spine. Kazan. 2010. (In Russ.)
  4. Barulin AE, Kurushina OV, Puchkov AE. Combination treatment for acute non-specific low back pain. Neurology, Neuropsychiatry, Psychosomatics. 2014;6(3):38-42. (InRuss.). doi: 10.14412/2074-2711-2014-3-38-42
  5. Figueiras A, Estany-Gestal A, Aguirre A, Ruiz B, Vidal X, Carvajal A, Salado I, Salgado-Barreira A, Rodella A, Moretti U, Ibanez L. On behalf of EMPHOGEN group. CYP2C9 variants as a risk modifier of a NSAID-related gastrointestinal bleeding: a case-control study. Pharmacogenetics and Genomics. 2016;26:66-73. doi: 10.1097/FPC.000000000000186
  6. Nagata N, Niikura R, Yamada A, Sakurai T, Shimbo T, Kobayashi Y. Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study. PLoSOne. 2016;11(3):0151332. doi: 10.1371/journal.pone.0151332
  7. Aminoshariae A, Kulild JC, Donaldson M. Short-term use of nonsteroidal anti-inflammatory drugs and adverse effects: An updated systematic review. J Am Dent Assoc. 2016;147(2):98-110. doi: 10.1016/j.adaj.2015.07.020
  8. Vanderstraeten G, Lejeune TM, Piessevaux H, De Bacquer D, Walker C, De Beleyr B. Gastrointestinal risk assessment in patients requiring non-steroidal anti-inflammatory drugs for osteoarthritis: The GIRANO study. J Rehabil Med. 2016. doi: 10.2340/16501977-2119
  9. Velasco-Zamora JA, Gómez-Reyes E, Uscanga L. Are the clinical guideline recommendations on gastroprotection being followed? A review in patients taking nonsteroidal anti-inflammatory drugs. Rev Gastroenterol Mex. 2016. doi: 10.1016/j.rgmx.2016.04.001
  10. Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2008;12(11):1-278.
  11. Zeidler H, Kaltwasser JP, Leonard JP, Kohlmann T, Sigmund R, Degner F, Hettich M. Prescription and tolerability of meloxicam in day-to-day practice: postmarketing observational cohort study of 13,307 patients in Germany. J Clin Rheumatol. 2002;8(6):305-315.
  12. Hawkey C, Kahan A, Steinbruck K, Alegre C, Baumelou E. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol. 1998;37:937-945. doi: 10.1093/rheumatology/37.9.937
  13. Grosser T, Fries S, Fitzgerald GA. Biological basis for the cardiovascular consequences of Cox 2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116:4-15. doi: 10.1172/JCI27291
  14. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):1001098. doi: 10.1371/journal.pmed.1001098
  15. Ungprasert P, Matteson E, Thongprayoon C. Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke. A Systematic Review and Meta-Analysis of Observational Studies. Stroke. 2016;47:356-364. doi: 10.1161/STROKEAHA.115.011678
  16. Olsen AM, Fosbøl E, Lindhardsen J, Folke F, Mette C, Selmer C, Olesen J, Lamberts M, Ruwald M. Long-Term Cardiovascular Risk of NSAID Use According to Time Passed After First-Time Myocardial Infarction: A Nationwide Cohort Study Running title: Olsen et al.; NSAIDs and Long-Term Risk after MI. Circulation. 2012;126(16):1955-1963. doi: 10.1161/CIRCULATIONAHA.112.112607
  17. Kohli P, Steg PG, Cannon CP, Smith SC, Eagle KA, Ohman EM, Alberts MJ, Hoffman E, Guo J, Simon T, Sorbets E, Goto S, Bhatt DL; REACH Registry. Investigators. NSAID Use and Association with Cardiovascular Outcomes in Outpatients with Stable Atherothrombotic Disease. Am J Med. 2014;127(1):53-60. doi: 10.1016/j.amjmed.2013.08.017
  18. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network metaanalysis. BMJ. 2011;342:7086. doi:10.1136/bmj.c7086
  19. Varas-Lorenzo С, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F, Nicotra F, Sturkenboom M, Perez-Gutthann S. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiology and Drug Safety. 2013;22:559-570. doi: 0.1002/pds.3437
  20. Chou CI, Shih CJ, Chen YT, Ou SM, Yang CY, Kuo SC, Chu D. Adverse Effects of Oral Nonselective and cyclooxygenase-2-Selective NSAIDs on Hospitalization for Acute Kidney Injury. A Nested Case—Control Cohort Study. Medicine (Baltimore). 2016;95(9):2645. doi: 10.1097/MD.0000000000002645
  21. Chang YK, Liu JS, Hsu YH, Tarng DC, Hsu CC.Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study. Medicine (Baltimore). 2015;94(38):1362. doi: 10.1097/MD.0000000000001362
  22. Hsu CC, Wang H, Hsu YH, Chuang SY, Huang YW, Chang YK, Liu JS, Hsiung CA, Tsai HJ.Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study. Hypertension. 2015;66(3):524-533. doi: 10.1161/HYPERTENSIONAHA.114.05105
  23. Schmeltzer PA, Kosinski AS, Kleiner DE, Hoofnagle JH, Stolz A, Fontana RJ, Russo MW; Drug-Induced Liver Injury Network (DILIN).Liver injury from nonsteroidal anti-inflammatory drugs in the United States. Liver Int. 2016;36(4):603-609. doi: 10.1111/liv.13032
  24. Anelli MG, Scioscia C, Grattagliano I, Lapadula G. Old and new antirheumatic drugs and the risk of hepatotoxicity. Ther Drug Monit. 2012;34(6):622-628. doi: 10.1097/FTD.0b013e31826a6306
  25. Agúndez JA, Lucena MI, Martínez C, Andrade RJ, Blanca M, Ayuso P, García-Martín E. Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol. 2011;7(7):817-828. doi: 10.1517/17425255.2011.574613
  26. Aithal GP. Hepatotoxicity related to antirheumatic drugs. Nat Rev Rheumatol. 2011;7(3):139-150. doi: 10.1038/nrrheum.2010.214
  27. Lavan AH, Gallagher PF, O’Mahony D. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clinical Interventionsin Aging. 2016;11:857-866. doi.org/10.2147/CIA.S80280
  28. Nardone R, Höller Y,Storti M, Christova M, Tezzon F, Golaszewski S, Trinka E, Brigo F. Thiamine Deficiency Induced Neurochemical, Neuroanatomical, and Neuropsychological Alterations: A Reappraisal. The Scientific World Journal. 2013. doi: 10.1155/2013/309143
  29. Scott J, Molloy A. The discovery of vitamin B(12). Ann Nutr Metab. 2012;61(3):239-245. doi: 10.1159/000343114
  30. Hosseinzadeh H, Moallem S, Moshiri M, Sarnavazi M, Etemad L. Anti-nociceptive and anti-inflammatory effects of cyanocobalamin (vitamin B12) against acute and chronic pain and inflammation in mice. Arzneimittelforschung. 2012;62(7):324-329. doi: 10.1055/s-0032-1311635
  31. Solomon LR. Diabetes as a cause of clinically significant functional cobalamin deficiency. Diabetes Care. 2011;34(5):1077-1080.
  32. Chiu C, Low T, Tey Y, Singh V, Shong H. The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial. Singapore Med J. 2011;52(12):868-873.
  33. Mibielli M, Geller M, Cohen J. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009;25(11):2589-2599. doi: 10.3111/13696990903246911
  34. Levin OS, Moseikin IA. Kompleks vitaminov gruppy B v lechenii diskogennoi poyasnichno-krestcovoi radiculopatii. Zhurn nevrol ipsichiatr im. S.S. Korsakova. 2009;119:10:30-35.
  35. Magaña-Villa M, Rocha-González H, Fernández del Valle-Laisequilla C, Granados-Soto V. B-vitamin mixture improves the analgesic effect of diclofenac in patients with osteoarthritis: a double blind study. Drug Res (Stuttg). 2013;63(6):289-292. doi: 10.1055/s-0033-1334963
  36. Batysheva TT, Otcheskaya OV, Khozova AA, Ganzhula PA, Kamchatnov PR, Boiko AN. Efficacy of the Combination of Arthrosan and Combilipen in Patients with Acute Lower Spinal Pain. Neuroscience and Behavioral Physiology. 2013;43:2:240-243. doi: 10.1007/s11055-013-9722-3
  37. Airaksinen O, Brox J, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G; COST B13 Working Group on Guidelines for Chronic Low Back Pain. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15(suppl 2):192-300. doi: 10.1007/s00586-006-1072-1
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.